On the origin of neutron magnetic scattering in anti-site disordered Sr2FeMoO6 double perovskites

Anti-site disordering in Sr2FeMoO6 double perovskites (containing Mo atoms at Fe positions, and viceversa) has recently been shown to have a dramatic influence in their magnetic and magnetotransport properties. In the present study, two polycrystalline Sr2FeMoO6 samples showing different degrees of anti-site disorder (a nominally 'ordered' sample with 70% of cationic ordering and a nominally 'disordered' sample with 18% of cationic ordering) have been examined by magnetic measurements and neutron powder diffraction (NPD) techniques in the 15-500K temperature range. Our main finding is that the 'disordered' sample exhibits a strong magnetic scattering (noticeable even at 500K), comparable to that displayed by the 'ordered' one below TC= 415 K. For the 'disordered' sample, the magnetic scattering exhibited on low angle Bragg positions, is not to be ascribed to a (non-existent) ferrimagnetic ordering: our results suggest that it originates upon naturally-occurring groups of Fe cations in which strong antiferromagnetic (AFM) Fe-O-Fe superexchange interactions are promoted, similar to those existing in the LaFeO3 perovskite. These Fe groups are not magnetically isolated, but coupled by virtue of Fe-O-Mo AFM interactions, which maintain the long-range coherence of this AFM structure. Susceptibility measurements confirm the presence of AFM interactions below 770 K.Comment: 30 pages, 11 figures, to be published in PR

Macrophage-Specific Chemokines Induced via Innate Immunity by Amino Acid Copolymers and Their Role in EAE

The random amino acid copolymer poly(Y,E,A,K)n (Copaxone®) is widely used in multiple sclerosis treatment and a second generation copolymer poly(Y,F,A,K)n with enhanced efficacy in experimental autoimmune encephalomyelitis in mice has been described. A major mechanism through which copolymers function to ameliorate disease is the generation of immunosuppressive IL-10-secreting regulatory T cells entering the CNS. In addition, the antigen presenting cell to which these copolymers bind through MHC Class II proteins may have an important role. Here, both CCL22 (a Th2 cell chemoattractant) in large amounts and CXCL13 in much smaller amounts are shown to be secreted after administration of YFAK to mice and to a smaller extent by YEAK parallel to their serum concentrations. Moreover, bone marrow-derived macrophages secrete CCL22 in vitro in response to YFAK and to higher concentrations of YEAK. Strikingly, these chemokines are also secreted into serum of MHC Class II −/− mice, indicating that an innate immune receptor on these cells also has an important role. Thus, both the innate and the adaptive immune systems are involved in the mechanism of EAE amelioration by YFAK. The enhanced ability of YFAK to stimulate the innate immune system may account for its enhanced efficacy in EAE treatment